Hangzhou Diagens Biotechnology Co., Ltd. (02526.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 425.00

From 52W high−40.25%

Volume78800.00

Market capHKD 38.40B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 425.00

From 52W high

−40.25%

Volume

78800.00

Market cap

HKD 38.40B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

48.0

MomentumView details →

1D Return

+5.37%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+5.37%

YTD Return

—

1Y Return

—

RSI (14)

48.0

vs 50D SMA

+5.94%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Desh-B (02526.HK) completed the upgrade of its AI medical platform, transitioning from an AI device manufacturer to an AI platform service provider, leveraging its self-developed iMedImage foundation model and iMedLoop standardized AI production line.44d ago

Hangzhou Desheng Biotech reported interim results for the six months ended June 2026, with revenue of 108.7 million RMB, up 21.0% year-on-year, and a widened net loss of 55.88 million RMB.44d ago

Similar companies

惠泰医疗688617.SH DexCom, Inc.DXCM Edwards Lifesciences CorporationEW Koninklijke Philips N.V.PHG Boston Scientific CorporationBSX Shanghai MicroPort MedBot (Group) Co., Ltd.02252.HK Find similar companies →

Latest newsMore news →

Desh-B (02526.HK) completed the upgrade of its AI medical platform, transitioning from an AI device manufacturer to an AI platform service provider, leveraging its self-developed iMedImage foundation model and iMedLoop standardized AI production line.44d ago Hangzhou Desheng Biotech reported interim results for the six months ended June 2026, with revenue of 108.7 million RMB, up 21.0% year-on-year, and a widened net loss of 55.88 million RMB.44d ago